KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Preferred Stock Liabilities (2019 - 2020)

GoodRx Holdings (GDRX) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $737.0 million as the latest value for Q2 2020.

  • Quarterly Preferred Stock Liabilities changed N/A to $737.0 million in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $737.0 million through Jun 2020, changed N/A year-over-year, with the annual reading at $737.0 million for FY2019, 0.0% changed from the prior year.
  • Preferred Stock Liabilities hit $737.0 million in Q2 2020 for GoodRx Holdings, roughly flat from $737.0 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $737.0 million in Q3 2019 to a low of $737.0 million in Q3 2019.